Thema
Journal Article
85
Research Support, N.I.H., Extramural
44
Antibodies, Viral
29
Influenza Vaccines
24
Research Support, Non-U.S. Gov't
23
Respiratory Syncytial Virus Vaccines
15
Vaccines, Virus-Like Particle
15
Immunoglobulin G
14
Adjuvants, Immunologic
13
Vaccines, Inactivated
11
Viral Matrix Proteins
10
Antibodies, Neutralizing
8
Cytokines
8
Adjuvant
7
Viral Fusion Proteins
7
influenza virus
7
Cross protection
6
Hemagglutinin Glycoproteins, Influenza Virus
6
Recombinant Fusion Proteins
6
615
5
82115-62-6
5
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
5
EC 3.2.1.18
5
Influenza virus
5
Interferon-gamma
5
M2 protein, Influenza A virus
5
Neuraminidase
5
RSV
5
Review
5
SARS-CoV-2
5
Toll-Like Receptor 2
5
che
5
F protein, human respiratory syncytial virus
4
FI-RSV
4
Influenza
4
Lipid A
4
M2e
4
MWC0ET1L2P
4
Reactive Oxygen Species
4
Respiratory syncytial virus
4
Vaccine enhanced disease
4
cross-protection
4
influenza
4
monophosphoryl lipid A
4
respiratory syncytial virus
4
207137-56-2
3
Aged mice
3
Antigens, Bacterial
3
Antimicrobial Cationic Peptides
3
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
3
mehr ...